2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The curious case of dermal fibroblasts: cell identity loss may be a mechanism underlying cardiovascular aging

      research-article
      Cardiovascular Research
      Oxford University Press

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Commentary on ‘Identity noise and adipogenic traits characterize dermal fibroblast aging’, by Salzer et al., Cell, 2018. 3 The greater longevity achieved by our society has brought the current research to give a particular interest on understanding the mechanisms underlying ageing, as age is the major risk factor for many pathologies, including cancer, neurodegeneration, and cardiovascular disease. 1 Ageing can be defined in general terms as a time-dependent structural and functional decline and the deterioration of the skin is one of the most apparent signs of it. The dermis, that is one of the three layers constituting the skin, is populated by fibroblasts that synthesize and secrete collagens and other matrix proteins that maintain the skin architecture and confer elasticity, resistance and strength to the tissue. 2 During ageing the dermis is characterized by loss of cellularity and extracellular matrix (ECM) remodelling. 2 , 3 Even though dermal fibroblasts have been widely used as an in vitro model of cellular ageing for decades, the molecular mechanisms leading to these cells ageing in vivo are poorly understood. 2 Dermal fibroblasts derive from mesenchymal progenitors and can be distinguished in the newborn dermis in four types: the papillary fibroblasts, which are restricted in the upper dermis, the reticular fibroblasts that are spread throughout the ECM dense lower dermis and two Sca1+ pro-adipogenic types, which are located in the lower reticular dermis. 4 However, in adulthood the cell surface epitopes that discriminate among these types of fibroblasts are lost and this compromises the possibility to investigate whether the adult dermis still contains these lineages. 4 Salzer et al., in a very recent issue of cell, addressed these gaps in our knowledge by means of bulk- and single-cell transcriptomic analyses and long-term lineage tracing. They found that during ageing dermal fibroblasts have a less well-defined identity, as the transcriptome features that define clusters in young cells become blurry with age, and paradoxically old fibroblasts acquire adipogenic traits reminiscent of newborn pro-adipogenic fibroblasts. 3 The intrinsic rate of skin ageing in every organism can be hugely affected by extrinsic factors, such as exposure to ultraviolet light; since dermal fibroblasts are long-lived cells that continuously accumulate damage, they are a preferred model to study extrinsic ageing at the cellular level. 2 However, although many studies display the beneficial effects of calorie restriction (CR) without malnutrition on longevity and age-related diseases, such as obesity, diabetes mellitus, cardiovascular disease, and cancer, the consequences of dietary interventions on dermal fibroblasts during ageing had been unexplored so far. 5 , 6 Hence, Salzer et al. 3 evaluated whether they could modulate the aged fibroblasts phenotype by feeding mice with a CR diet or a high fat diet (HFD). Interestingly, they found that CR could prevent the loss of papillary characteristics and the gain of adipogenic traits in old fibroblasts and that the transcriptome of adult dermal fibroblasts isolated from HFD-fed mice positively correlated with the one of old fibroblasts; these results indicate that CR and HFD could respectively delay and accelerate the ageing processes of these cells. 3 Hence, they suggested loss of cell identity as a mechanism underlying cellular ageing and dietary intervention as a possible therapeutic strategy to slow down skin ageing. This study that employs state of the art techniques to decipher fibroblast ageing in vivo has surely a high impact in the poorly understood field of skin dermis ageing; but, I believe that it also has a broader relevance comprising the cardiovascular field. For instance, if loss of cell identity is a possible mechanism underlying ageing, this could also explain what occurs in the aged heart and vessels, as cardiac fibroblasts and vascular smooth muscle cells (VSMC), which similarly to dermal fibroblasts play crucial structural and functional roles in their tissues, are more prone to phenotypic shifts that lead to age-related dysfunctions, such as cardiac fibrosis and vascular calcification, respectively. 7–9 Interestingly, both myofibroblasts and VSMC transdifferentiating towards an osteochondrogenic lineage display altered expression of ECM-related genes and increased expression of pro-inflammatory factors 9–12 ; similarly, Salzer et al. 3 observed that old fibroblasts, along with acquiring the newly identified feature of cell identity loss, exhibited these two typical characteristics of aged cells, as well as they up-regulated the expression of genes involved in adipogenesis. Although VSMC grown in apidogenic media develop adipocyte markers, it still has to be determined whether these cells, as well as cardiac fibroblasts, are able to acquire these adipogenic traits during ageing and, if so, it would be interesting to evaluate which are the consequences of this shift on the cardiovascular system. 9 Intriguingly, the same cutting-edge approach of combining single-cell RNA sequencing and lineage tracing has been employed to unveil similar mechanisms in cardiovascular diseases. Indeed, Kretzschmar et al. 13 in a very recent study observed that a subpopulation of activated fibroblasts acquires a neonatal-like gene expression profile in response to ischaemic injury; it is thus tempting to speculate that this cellular attempt of rejuvenation towards a neonatal-like state may be an adaptive mechanism that at least fibroblasts could adopt to respond to different insults, such as cardiac damage and skin ageing. Moreover, Dobnikar et al. investigated the transcriptional signatures of VSMC in healthy and atherosclerotic vessels and found a subpopulation of lineage-traced VSMC positive for the progenitor cell marker Sca1 that they suggested to be involved in the vessel response to injury; they also observed Sca1 up-regulation in VSMC exposed to stimuli that are known to induce the phenotypic switching of these cells. 14 However, whether the loss of identity that may enable cells to acquire a stem/progenitor-like phenotype, possibly as an adaptive response to the age-related stem cell exhaustion, occurs in cardiac fibroblasts or VSMC during ageing still remains to be elucidated. Hence, the future research that aims to decipher the molecular and cellular mechanisms controlling cardiovascular ageing and age-related diseases should reckon with the findings described by Salzer et al., that may be even extended to other organs and tissues. Conflict of interest: none declared. Funding This work was supported by the British Heart Foundation (FS/16/15/32047).

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Cardiac Fibrosis: The Fibroblast Awakens.

          Myocardial fibrosis is a significant global health problem associated with nearly all forms of heart disease. Cardiac fibroblasts comprise an essential cell type in the heart that is responsible for the homeostasis of the extracellular matrix; however, upon injury, these cells transform to a myofibroblast phenotype and contribute to cardiac fibrosis. This remodeling involves pathological changes that include chamber dilation, cardiomyocyte hypertrophy and apoptosis, and ultimately leads to the progression to heart failure. Despite the critical importance of fibrosis in cardiovascular disease, our limited understanding of the cardiac fibroblast impedes the development of potential therapies that effectively target this cell type and its pathological contribution to disease progression. This review summarizes current knowledge regarding the origins and roles of fibroblasts, mediators and signaling pathways known to influence fibroblast function after myocardial injury, as well as novel therapeutic strategies under investigation to attenuate cardiac fibrosis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Distinct fibroblast lineages determine dermal architecture in skin development and repair

            Fibroblasts are the major mesenchymal cell type in connective tissue and deposit the collagen and elastic fibers of the extracellular matrix (ECM) 1 . Even within a single tissue fibroblasts exhibit remarkable functional diversity, but it is not known whether this reflects the existence of a differentiation hierarchy or is a response to different environmental factors. Here we show, using transplantation assays and lineage tracing, that the fibroblasts of skin connective tissue arise from two distinct lineages. One forms the upper dermis, including the dermal papilla that regulates hair growth and the arrector pili muscle (APM), which controls piloerection. The other forms the lower dermis, including the reticular fibroblasts that synthesise the bulk of the fibrillar ECM, and the pre-adipocytes and adipocytes of the hypodermis. The upper lineage is required for hair follicle formation. In wounded adult skin, the initial wave of dermal repair is mediated by the lower lineage and upper dermal fibroblasts are recruited only during re-epithelialisation. Epidermal beta-catenin activation stimulates expansion of the upper dermal lineage, rendering wounds permissive for hair follicle formation. Our findings explain why wounding is linked to formation of ECM-rich scar tissue that lacks hair follicles 2-4 . They also form a platform for discovering fibroblast lineages in other tissues and for examining fibroblast changes in ageing and disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels

              Vascular smooth muscle cells (VSMCs) show pronounced heterogeneity across and within vascular beds, with direct implications for their function in injury response and atherosclerosis. Here we combine single-cell transcriptomics with lineage tracing to examine VSMC heterogeneity in healthy mouse vessels. The transcriptional profiles of single VSMCs consistently reflect their region-specific developmental history and show heterogeneous expression of vascular disease-associated genes involved in inflammation, adhesion and migration. We detect a rare population of VSMC-lineage cells that express the multipotent progenitor marker Sca1, progressively downregulate contractile VSMC genes and upregulate genes associated with VSMC response to inflammation and growth factors. We find that Sca1 upregulation is a hallmark of VSMCs undergoing phenotypic switching in vitro and in vivo, and reveal an equivalent population of Sca1-positive VSMC-lineage cells in atherosclerotic plaques. Together, our analyses identify disease-relevant transcriptional signatures in VSMC-lineage cells in healthy blood vessels, with implications for disease susceptibility, diagnosis and prevention.
                Bookmark

                Author and article information

                Journal
                Cardiovasc Res
                Cardiovasc. Res
                cardiovascres
                Cardiovascular Research
                Oxford University Press
                0008-6363
                1755-3245
                01 March 2019
                20 February 2019
                20 February 2019
                : 115
                : 3
                : e24-e25
                Affiliations
                Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Level 6 West Wing, Headley Way, Oxford, UK
                Author notes
                Corresponding author. Tel: +44 (0) 1865 572898; E-mail: ileana.badi@ 123456cardiov.ox.ac.uk
                Article
                cvz012
                10.1093/cvr/cvz012
                6383055
                30753353
                7a2ebe6b-8103-47fc-a4ad-b2db682c4e37
                © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Pages: 2
                Funding
                Funded by: British Heart Foundation 10.13039/501100000274
                Award ID: FS/16/15/32047
                Categories
                Cardiovascular Research Onlife
                Spotted by the Scientists of Tomorrow

                Cardiovascular Medicine
                Cardiovascular Medicine

                Comments

                Comment on this article